Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-08

Clinical Trial Update: Validation of the REMINDER Dementia Risk Reduction Program [NA]

View source ↗

Summary

This entry reports an ongoing clinical trial evaluating the REMINDER dementia risk reduction program in healthy aging adults. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Coimbra | Conditions: Healthy Aging, Risk Reduction | NA | Status: RECRUITING